For Medical Affairs Support
and Other Enquiries:

If you would like additional medical information about Vizamyl, please contact us by email at

For other enquiries, including requests related to image reader training, please contact us by email at

Adverse events or complaints should be immediately reported to the Pharmacovigliance Safety Group at
800 654 0118 or by email at

Should the reporter not wish to contact GE Healthcare, adverse can also be reported to the U.S Food & Drug Administration at 800 FDA 1088 or at